InvestSMART

Respiri Limited (ASX:RSH)

ALERT: Price-sensitive ASX Announcement for RSH
Current share price for RSH : $0.033 0.004 (13.79%)+
Release
9 Apr 2025 9:28AM
Price at Release
$0.029
Full Release
download
Summary
Respiri Limited has announced that recent developments in U.S. health policy and trade support its remote patient monitoring strategy. U.S. Health Secretary Robert F. Kennedy Jr. has endorsed AI and telehealth as vital for improving healthcare access, which aligns with Respiri's Connected Care model. The impact of new tariffs on Chinese medical devices on Respiri's operations will be minimal due to existing inventory and the company's commitment to absorb any tariff-related cost increases. The company ensures uninterrupted service to clients and continues to expand its operations with no disruptions.
Key Points
  • U.S. Health Secretary endorses AI and telehealth solutions.
  • Virtual care technologies are crucial for rural healthcare services.
  • U.S. tariffs on Chinese medical devices will not disrupt operations.
  • Respiri will absorb expected tariff-related cost increases.
  • No changes in customer pricing or service disruptions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.